中草药

人工智能驱动的类器官/器官芯片：中药及民族药药效物质和靶标发现新范式

PDF下载

徐鑫梅, 干志强, 李睿琪, 徐僮, 范刚, 艾永建, 孟宪丽, 梁琼麟, 张艺

中草药 | 专论 2026,57(1): 1-12

收起

中草药 |专论 2026 , 57 (1) : 1 -12

人工智能驱动的类器官/器官芯片：中药及民族药药效物质和靶标发现新范式

全屏

徐鑫梅, 干志强, 李睿琪, 徐僮, 范刚, 艾永建, 孟宪丽, 梁琼麟, 张艺

作者信息

通讯作者:

梁琼麟

作者简介:

徐鑫梅: 徐鑫梅,博士研究生,研究方向为中药及民族药药效物质和作用机制。E-mail:Xinmei Xu123@163.com

Artificial intelligence-enabled organoids/organ-on-a-chip: A new paradigm for discovering active ingredients and targets of traditional Chinese medicine and ethnic medicine

XU Xinmei, GAN Zhiqiang, LI Ruiqi, XU Tong, FAN Gang, AI Yongjian, MENG Xianli, LIANG Qionglin, ZHANG Yi

Affiliations

doi: 10.7501/j.issn.0253-2670.2026.01.001

文章导航

摘要

收起

中药及民族药作为传统医学的重要组成部分，其功效多元化、化学成分多样化、体内过程复杂化及作用机制多维化等特征，使得阐明中药及民族药的药效物质基础和作用机制成为中医药研究的重要方向之一。然而，药效作用评价模型不完善、临床功效关联度不高、筛选效率与通量较低等瓶颈仍是当前的核心挑战。人工智能驱动的类器官与器官芯片技术为中药及民族药的药效物质筛选与靶标机制发现提供了颠覆性新技术。通过构建高仿生人源类器官/器官芯片模型，精准模拟人体器官微环境及病理状态，结合人工智能技术对高通量药效数据进行深度挖掘与分析，实现多组分、多靶点的协同效应解析。系统筛选中药活性成分群，量化其代谢动力学过程，并揭示潜在作用靶点与分子通路，显著提升药效物质辨识的精准性和效率。类器官/器官芯片与人工智能的深度融合将加速中药与民族药物现代化研究，为推动创新药物开发提供前沿技术支撑。

关键词

类器官 / 器官芯片 / 人工智能 / 中药 / 民族药

Abstract

收起

Traditional Chinese medicine（TCM） and ethnic medicine, as integral components of traditional medicine, exhibit diverse therapeutic effects, complex chemical compositions, intricate physiological processes, and multifaceted mechanisms of action. This makes elucidating the pharmacological basis and mechanisms of action of TCM and ethnic medicine a key research direction in the modernization of TCM. However, challenges such as incomplete pharmacological evaluation models, low correlation with clinical efficacy, and low screening efficiency and throughput remain core obstacles. Artificial intelligence-driven organoid and organ-on-achip technologies offer an innovative research paradigm for the screening of bioactive compounds and the discovery of target mechanisms in TCM and ethnic medicines. By constructing highly biomimetic human organoids/organ-on-a-chip models that precisely simulate the microenvironment and pathological states of human organs, combined with artificial intelligence technologies for in-depth analysis of high-throughput pharmacodynamic data, it is possible to elucidate the synergistic effects of multi-component, multi-target interactions. Systematically screening groups of active components in TCM, quantifying their metabolic kinetic processes, and revealing potential target points and molecular pathways significantly enhances the precision and efficiency of bioactive substance identification. The deep integration strategy of organoids/organ-on-a-chip technology with artificial intelligence provides new technical support for accelerating the modernization of TCM and ethnic medicine research and promoting innovative drug development.

Key words

organoids / organ-on-a-chip / artificial intelligence / traditional Chinese medicine / ethnic medicine

引用本文

徐鑫梅, 干志强, 李睿琪, 徐僮, 范刚, 艾永建, 孟宪丽, 梁琼麟, 张艺. 人工智能驱动的类器官/器官芯片：中药及民族药药效物质和靶标发现新范式. 中草药, 2026 , 57 (1) : 1 -12 . DOI: 10.7501/j.issn.0253-2670.2026.01.001

XU Xinmei, GAN Zhiqiang, LI Ruiqi, XU Tong, FAN Gang, AI Yongjian, MENG Xianli, LIANG Qionglin, ZHANG Yi. Artificial intelligence-enabled organoids/organ-on-a-chip: A new paradigm for discovering active ingredients and targets of traditional Chinese medicine and ethnic medicine[J]. Chinese Traditional and Herbal Drugs, 2026 , 57 (1) : 1 -12 . DOI: 10.7501/j.issn.0253-2670.2026.01.001

基金

收起

国家重点研发计划资助项目 (2023YFC3504401,2023YFC3504402,2023YFC3504403,2022YFA1103403); 国家自然科学基金重点项目 (82130113); 四川省自然科学基金项目 (2024NSFSC0701); 中国科协青年人才托举工程博士生专项计划 (156-O-360-0000283-2)

参考文献

收起

文献

收起

参考文献引证文献

排序方式：

Low L A, Mummery C, Berridge B R, et al. Organs-onchips:Into the next decade[J]. Nat Rev Drug Discov, 2021,20(5):345-361.
Ma C, Peng Y S, Li H T, et al. Organ-on-a-chip:A new paradigm for drug development[J]. Trends Pharmacol Sci,2021, 42(2):119-133.
Leung C M, de Haan P, Ronaldson-Bouchard K, et al. A guide to the organ-on-a-chip[J]. Nat Rev Meth Primers,2022, 2:33.
Zhao Z, Chen X, Dowbaj A M, et al. Organoids[J]. Nat Rev Methods Primers, 2022, 2:94.
Takebe T, Wells J M. Organoids by design[J]. Science,2019, 364(6444):956-959.
Xu X M, Cheung S, Jia X M, et al. Trends in organ-on-achip for pharmacological analysis[J]. Trac Trends Anal Chem, 2024, 180:117905.
Park S E, Georgescu A, Huh D. Organoids-on-a-chip[J]. Science, 2019, 364(6444):960-965.
Zhao Y M, Landau S, Okhovatian S, et al. Integrating organoids and organ-on-a-chip devices[J]. Nat Rev Bioeng, 2024, 2:588-608.
Greener J G, Kandathil S M, Moffat L, et al. A guide to machine learning for biologists[J]. Nat Rev Mol Cell Biol,2022, 23(1):40-55.
Hao H Y, Xue Y F, Wu Y H, et al. A paradigm for highthroughput screening of cell-selective surfaces coupling orthogonal gradients and machine learning-based cell recognition[J]. Bioact Mater, 2023, 28:1-11.
Bai L, Wu Y, Li G F, et al. AI-enabled organoids:Construction, analysis, and application[J]. Bioact Mater,2023, 31:525-548.
解文欣,张紫萱,刘越,等.人工智能在中药质量中的应用及研究进展[J]. 中草药, 2025, 56(15):5616-5631.
Zhou L B, Chen S S, Liu J, et al. When artificial intelligence(AI)meets organoids and organs-on-chips(OoCs):Game-changer for drug discovery and development?[J]. Innov Life, 2025, 3(1):100115.
Deng S W, Li C F, Cao J X, et al. Organ-on-a-chip meets artificial intelligence in drug evaluation[J]. Theranostics,2023, 13(13):4526-4558.
Sakalem M E, De Sibio M T, da Costa F A D S, et al.Historical evolution of spheroids and organoids, and possibilities of use in life sciences and medicine[J]. Biotechnol J, 2021, 16(5):e2000463.
Sato T, Vries R G, Snippert H J, et al. Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche[J]. Nature, 2009, 459(7244):262-265.
Lancaster M A, Renner M, Martin C A, et al. Cerebral organoids model human brain development and microcephaly[J]. Nature, 2013, 501(7467):373-379.
Andersen J, Revah O, Miura Y, et al. Generation of functional human 3D cortico-motor assembloids[J]. Cell,2020, 183(7):1913-1929.e26.
Barker N, Huch M, Kujala P, et al. Lgr5(+ve)stem cells drive self-renewal in the stomach and build long-lived gastric units in vitro[J]. Cell Stem Cell, 2010, 6(1):25-36.
Drost J, Karthaus W R, Gao D, et al. Organoid culture systems for prostate epithelial and cancer tissue[J]. Nat Protoc, 2016, 11(2):347-358.
Dye B R, Hill D R, Ferguson M A H, et al. In vitro generation of human pluripotent stem cell derived lung organoids[J]. e Life, 2015, 4:e05098.
Eiraku M, Takata N, Ishibashi H, et al. Self-organizing optic-cup morphogenesis in three-dimensional culture[J]. Nature, 2011, 472(7341):51-56.
Huch M, Bonfanti P, Boj S F, et al. Unlimited in vitro expansion of adult bi-potent pancreas progenitors through the Lgr5/R-spondin axis[J]. EMBO J, 2013, 32(20):2708-2721.
Miura Y, Li M Y, Birey F, et al. Generation of human striatal organoids and cortico-striatal assembloids from human pluripotent stem cells[J]. Nat Biotechnol, 2020, 38:1421-1430.
Takebe T, Sekine K, Enomura M, et al. Vascularized and functional human liver from an iPSC-derived organ bud transplant[J]. Nature, 2013, 499(7459):481-484.
Xia Y, Nivet E, Sancho-Martinez I, et al. Directed differentiation of human pluripotent cells to ureteric bud kidney progenitor-like cells[J]. Nat Cell Biol, 2013,15(12):1507-1515.
Zhang B Y, Korolj A, Lai B F L, et al. Advances in organon-a-chip engineering[J]. Nat Rev Mater, 2018, 3:257-278.
Vunjak-Novakovic G, Ronaldson-Bouchard K, Radisic M.Organs-on-a-chip models for biological research[J]. Cell,2021, 184(18):4597-4611.
Ronaldson-Bouchard K, Vunjak-Novakovic G. Organson-a-chip:A fast track for engineered human tissues in drug development[J]. Cell Stem Cell, 2018, 22(3):310-324.
Vogt N. Modeling multi-organ systems on a chip[J]. Nat Methods, 2022, 19(6):641.
Huh D, Torisawa Y S, Hamilton G A, et al.Microengineered physiological biomimicry:Organs-onchips[J]. Lab Chip, 2012, 12(12):2156-2164.
Lind J U, Busbee T A, Valentine A D, et al. Instrumented cardiac microphysiological devices via multimaterial three-dimensional printing[J]. Nat Mater, 2017, 16(3):303-308.
Ma C, Zhao L, Zhou E M, et al. On-chip construction of liver lobule-like microtissue and its application for adverse drug reaction assay[J]. Anal Chem, 2016, 88(3):1719-1727.
Miller J S, Stevens K R, Yang M T, et al. Rapid casting of patterned vascular networks for perfusable engineered three-dimensional tissues[J]. Nat Mater, 2012, 11(9):768-774.
Ronaldson-Bouchard K, Teles D, Yeager K, et al. A multiorgan chip with matured tissue niches linked by vascular flow[J]. Nat Biomed Eng, 2022, 6(4):351-371.
Zhang Y S, Aleman J, Shin S R, et al. Multisensorintegrated organs-on-chips platform for automated and continual in situ monitoring of organoid behaviors[J]. Proc Natl Acad Sci USA, 2017, 114(12):E2293-E2302.
Zhao Y M, Rafatian N, Feric N T, et al. A platform for generation of chamber-specific cardiac tissues and disease modeling[J]. Cell, 2019, 176(4):913-927.
王俊龙,傅丽霞,王青洋,等.类器官技术在新药评价中的应用进展[J]. 中国新药杂志, 2024, 33(20):2131-2137.
汪祺,邵子轩,文海若.类器官在药物筛选及安全性评价中的应用进展[J]. 药物评价研究, 2025, 48(8):2065-2074.
Achberger K, Probst C, Haderspeck J, et al. Merging organoid and organ-on-a-chip technology to generate complex multi-layer tissue models in a human retina-on-achip platform[J]. e Life, 2019, 8:e46188.
Homan K A, Gupta N, Kroll K T, et al. Flow-enhanced vascularization and maturation of kidney organoids in vitro[J]. Nat Methods, 2019, 16(3):255-262.
Lai Benjamin F L, Rick X L, Hu Y S, et al. Recapitulating pancreatic tumor microenvironment through synergistic use of patient organoids and organ-on-a-chip vasculature[J]. Adv Funct Mater, 2020, 30(48):2000545.
Nikolaev M, Mitrofanova O, Broguiere N, et al.Homeostatic mini-intestines through scaffold-guided organoid morphogenesis[J]. Nature, 2020, 585(7826):574-578.
Salmon I, Grebenyuk S, Abdel Fattah A R, et al.Engineering neurovascular organoids with 3D printed microfluidic chips[J]. Lab Chip, 2022, 22(8):1615-1629.
Shirure V S, Bi Y, Curtis M B, et al. Tumor-on-a-chip platform to investigate progression and drug sensitivity in cell lines and patient-derived organoids[J]. Lab Chip,2018, 18(23):3687-3702.
Deng L. Artificial intelligence in the rising wave of deep learning:The historical path and future outlook[perspectives[J]. IEEE Signal Process Mag, 2018, 35(1):180-177.
Gan Z Q, Qin X Y, Liu H T, et al. Recent advances in defined hydrogels in organoid research[J]. Bioact Mater,2023, 28:386-401.
Verheyen C A, Uzel S G M, Kurum A, et al. Integrated data-driven modeling and experimental optimization of granular hydrogel matrices[J]. Matter, 2023, 6(3):1015-1036.
Ma L, Yu S J, Xu X D, et al. Application of artificial intelligence in 3D printing physical organ models[J]. Mater Today Bio, 2023, 23:100792.
Wang J C, Liang K C, Zhang N Y, et al. Automated calibration of 3D-printed microfluidic devices based on computer vision[J]. Biomicrofluidics, 2021, 15(2):024102.
Zhu Y J, Huang R Q, Wu Z R, et al. Deep learning-based predictive identification of neural stem cell differentiation[J]. Nat Commun, 2021, 12(1):2614.
So C, Kim J U, Luan H W, et al. Epidermal piezoresistive structure with deep learning-assisted data translation[J]. NPJ Flex Electron, 2022, 6:70.
Gritti N, Lim J L, AnlaşK, et al. MOrgAna:Accessible quantitative analysis of organoids with machine learning[J]. Development, 2021, 148(18):dev199611.
Mergenthaler P, Hariharan S, Pemberton J M, et al. Rapid3D phenotypic analysis of neurons and organoids using data-driven cell segmentation-free machine learning[J]. PLoS Comput Biol, 2021, 17(2):e1008630.
Albanese A, Swaney J M, Yun D H, et al. Multiscale 3D phenotyping of human cerebral organoids[J]. Sci Rep,2020, 10(1):21487.
Pérez-Aliacar M, Doweidar M H, DoblaréM, et al.Predicting cell behaviour parameters from glioblastoma on a chip images. A deep learning approach[J]. Comput Biol Med, 2021, 135:104547.
Cascarano P, Comes M C, Mencattini A, et al. Recursive Deep Prior Video:A super resolution algorithm for timelapse microscopy of organ-on-chip experiments[J]. Med Image Anal, 2021, 72:102124.
Mencattini A, Di Giuseppe D, Comes M C, et al.Discovering the hidden messages within cell trajectories using a deep learning approach for in vitro evaluation of cancer drug treatments[J]. Sci Rep, 2020, 10(1):7653.
Goldhammer N, Kim J, Timmermans-Wielenga V, et al.Characterization of organoid cultured human breast cancer[J]. Breast Cancer Res, 2019, 21(1):141.
Cowan C S, Renner M, De Gennaro M, et al. Cell types of the human retina and its organoids at single-cell resolution[J]. Cell, 2020, 182(6):1623-1640.
Rodrigues D, de Souza T, Coyle L, et al. New insights into the mechanisms underlying 5-fluorouracil-induced intestinal toxicity based on transcriptomic and metabolomic responses in human intestinal organoids[J]. Arch Toxicol, 2021, 95(8):2691-2718.
Tang X, Zhang J W, He Y C, et al. Explainable multi-task learning for multi-modality biological data analysis[J]. Nat Commun, 2023, 14(1):2546.
Galdos F X, Xu S, Goodyer W R, et al. devCellPy is a machine learning-enabled pipeline for automated annotation of complex multilayered single-cell transcriptomic data[J]. Nat Commun, 2022, 13(1):5271.
Del Río J S, Ro J, Yoon H, et al. Integrated technologies for continuous monitoring of organs-on-chips:Current challenges and potential solutions[J]. Biosens Bioelectron,2023, 224:115057.
Young A T, Rivera K R, Erb P D, et al. Monitoring of microphysiological systems:Integrating sensors and realtime data analysis toward autonomous decision-making[J]. ACS Sens, 2019, 4(6):1454-1464.
Galan E A, Zhao H R, Wang X K, et al. Intelligent microfluidics:The convergence of machine learning and microfluidics in materials science and biomedicine[J]. Matter, 2020, 3(6):1893-1922.
Isozaki A, Harmon J, Zhou Y, et al. AI on a chip[J]. Lab Chip, 2020, 20(17):3074-3090.
Cai H W, Ao Z, Tian C H, et al. Brain organoid reservoir computing for artificial intelligence[J]. Nat Electron,2023, 6:1032-1039.
Hiratsuka K, Miyoshi T, Kroll K T, et al. Organoid-on-achip model of human ARPKD reveals mechanosensing pathomechanisms for drug discovery[J]. Sci Adv, 2022,8(38):eabq0866.
LasséM, El Saghir J, Berthier C C, et al. An integrated organoid omics map extends modeling potential of kidney disease[J]. Nat Commun, 2023, 14(1):4903.
Zhu W D, Wu Y, Li X, et al. A stroke organoids-multiomics platform to study injury mechanism and drug response[J]. Bioact Mater, 2025, 44:68-81.
Lin H R, Cheng J J, Zhu C W, et al. Artificial intelligenceenabled quantitative assessment and intervention for heart inflammation model organoids[J]. Angew Chem Int Ed,2025, 64(25):e202503252.
Novak R, Ingram M, Marquez S, et al. Robotic fluidic coupling and interrogation of multiple vascularized organ chips[J]. Nat Biomed Eng, 2020, 4(4):407-420.
Tao T T, Deng P W, Wang Y Q, et al. Microengineered multi-organoid system from hiPSCs to recapitulate human liver-islet axis in normal and type 2 diabetes[J]. Adv Sci,2022, 9(5):e2103495.
Trietsch S J, Naumovska E, Kurek D, et al. Membrane-free culture and real-time barrier integrity assessment of perfused intestinal epithelium tubes[J]. Nat Commun,2017, 8(1):262.
Ai X N, Wu Y, Lu W B, et al. A precise microfluidic assay in single-cell profile for screening of transient receptor potential channel modulators[J]. Adv Sci, 2020, 7(11):2000111.
Gou H Y, Su H, Liu D H, et al. Traditional medicine pien tze Huang suppresses colorectal tumorigenesis through restoring gut microbiota and metabolites[J]. Gastroenterology, 2023, 165(6):1404-1419.
Gao Z, Du Z Y, Hou Y, et al. A microfluidic coculture model for mapping signaling perturbations and precise drug screening against macrophage-mediated dynamic myocardial injury[J]. Acta Pharm Sin B, 2024, 14(12):5393-5406.
Prantil-Baun R, Novak R, Das D, et al. Physiologically based pharmacokinetic and pharmacodynamic analysis enabled by microfluidically linked organs-on-chips[J]. Annu Rev Pharmacol Toxicol, 2018, 58:37-64.
Ingber D E. Human organs-on-chips for disease modelling,drug development and personalized medicine[J]. Nat Rev Genet, 2022, 23(8):467-491.
Herland A, Maoz B M, Das D, et al. Quantitative prediction of human pharmacokinetic responses to drugs via fluidically coupled vascularized organ chips[J]. Nat Biomed Eng, 2020, 4:421-436.
Zhang S, Liu F B, Li J M, et al. A 4.7-kDa polysaccharide from Panax ginseng suppresses Aβ pathology via mitophagy activation in cross-species Alzheimer’s disease models[J]. Biomed Pharmacother, 2023, 167:115442.
Yan Z Q, Li Y S, Xia T T, et al. Revitalizing gut health:Liangxue Guyuan Yishen Decoction promotes Akkermansia muciniphila-induced intestinal stem cell recovery post-radiation in mice[J]. Phytomedicine, 2024,132:155888.
Chen S Y, Fan F F, Zhang Y R, et al. Metabolites from scutellarin alleviating deferoxamine-induced hypoxia injury in BV2 cells cultured on microfluidic chip combined with a mass spectrometer[J]. Talanta, 2023,259:124478.
Chen S Y, Li Y X, Zhang Y R, et al. Establishment of microneurovascular units in alginate hydrogel microspheres to reveal the anti-hypoxic effect of salidroside[J]. J Pharm Anal, 2024, 14(6):100967.
李婷婷,李瑞红,刘振兴,等.基于类器官3D培养的何首乌易感物质肝毒性评价[J]. 药学学报, 2017,52(7):1048-1054.

2026年第57卷第1期

PDF下载

引用本文

BibTeX

文章信息

doi: 10.7501/j.issn.0253-2670.2026.01.001

接收时间：2025-08-13
首发时间：2026-09-09

补充材料

相关文章

文章信息

作者

出版历史

收稿日期：2025-08-13

基金

作者信息

参考文献

分享链接

https://castjournals.cast.org.cn/joweb/zcy/CN/10.7501/j.issn.0253-2670.2026.01.001

分享至

全文二维码

扫描看全文

引用本文

BibTeX

本文的引用情况

2种不同金属材料的力学参数

科 Family	属数 Number of genus	种数 Number of species	占总种数比例 Percentage of total species (%)	属 Genus	种数 Number of species	占总种数比例 Percentage of total species (%)
鹅膏菌科Amanitaceae	2	11	5.26	鹅膏菌属 Amanita	10	4.78
小菇科 Mycenaceae	2	12	5.74	丝盖伞属 Inocybe	5	2.39
多孔菌科 Polyporaceae	8	14	6.70	蜡蘑属 Laccaria	5	2.39
红菇科 Russulaceae	3	23	11.00	小皮伞属 Marasmius	6	2.87
				小菇属 Mycena	11	5.26
				光柄菇属 Pluteus	5	2.39
				红菇属 Russula	17	8.13
				栓菌属 Trametes	5	2.39

关闭全屏

BibTeX
EndNote
RefWorks
TxT